Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe for Symptomatic Treatment of Primary Biliary Cirrhosis
NCT00125281Phase 2Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of S-adenosylmethionine in primary biliary cholangitis (PBC), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jul 2005; status: terminated.
02
Drugs
S-adenosylmethionine
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT00125281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125281.